In the neoadjuvant setting of melanoma treatment, combination therapy of ipilimumab to nivolumab resulted in severe irAEs reaching up to 90% [6]
In the neoadjuvant setting of melanoma treatment, combination therapy of ipilimumab to nivolumab resulted in severe irAEs reaching up to 90% [6]. would be more common and so irAEs. irAEs…